You just read:

Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy

News provided by

Amsterdam Molecular Therapeutics (AMT) B.V

16 Nov, 2011, 06:00 GMT